Research Papers

22 of 347 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Modulation of vaccine response by concomitant probiotic administration.
Maidens C; Childs C; Przemska A; Dayel IB; Yaqoob P.
Br J Clin Pharmacol (Unknown)
Published: 2013
2/6 Transparent
Funding Declared
First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative …
Moehrle JJ; Duparc S; Siethoff C; van Giersbergen PL; Craft JC; Arbe-Barnes S; Charman SA; Gutierrez M; Wittlin S; Vennerstrom JL.
Br J Clin Pharmacol (Unknown)
Published: 2013
1/6 Transparent
The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics.
van Hasselt JG; Andrew MA; Hebert MF; Tarning J; Vicini P; Mattison DR.
Br J Clin Pharmacol (Unknown)
Published: 2012
2/6 Transparent
Funding Declared
Cluster randomized trials of prescription medicines or prescribing policy: public and general practitioner opinions in …
Mackenzie IS; Wei L; Paterson KR; Macdonald TM.
Br J Clin Pharmacol (Unknown)
Published: 2012
1/6 Transparent
Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse…
Mackenzie IS; MacDonald TM; Shakir S; Dryburgh M; Mantay BJ; McDonnell P; Layton D.
Br J Clin Pharmacol (Unknown)
Published: 2012
2/6 Transparent
Funding Declared
Pleiotropic effects of pitavastatin.
Davignon J.
Br J Clin Pharmacol (Unknown)
Published: 2012
1/6 Transparent
Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positi…
Mendzelevski B; Ausma J; Chanter DO; Robinson P; Kerstens R; Vandeplassche L; Camm J.
Br J Clin Pharmacol (Unknown)
Published: 2012
2/6 Transparent
Funding Declared
The association between antipsychotic agents and the risk of myocardial infarction: a systematic review.
Brauer R; Douglas I; Smeeth L.
Br J Clin Pharmacol (Unknown)
Published: 2011
2/6 Transparent
Funding Declared
An investigation of the safety and pharmacokinetics of the novel TRPV1 antagonist XEN-D0501 in healthy subjects.
Round P; Priestley A; Robinson J.
Br J Clin Pharmacol (Unknown)
Published: 2011
1/6 Transparent
Anti-platelet therapy: ADP receptor antagonists.
Wijeyeratne YD; Heptinstall S.
Br J Clin Pharmacol (Unknown)
Published: 2011
2/6 Transparent
Funding Declared
Impact of allopurinol use on urate concentration and cardiovascular outcome.
Wei L; Mackenzie IS; Chen Y; Struthers AD; MacDonald TM.
Br J Clin Pharmacol (Unknown)
Published: 2011
2/6 Transparent
Funding Declared
Influence of hepatic impairment on pharmacokinetics of the human GLP-1 analogue, liraglutide.
Flint A; Nazzal K; Jagielski P; Hindsberger C; Zdravkovic M.
Br J Clin Pharmacol (Unknown)
Published: 2010
2/6 Transparent
Funding Declared
Effectiveness, safety and cost of drug substitution in hypertension.
Johnston A; Stafylas P; Stergiou GS.
Br J Clin Pharmacol (Unknown)
Published: 2010
1/6 Transparent
Promoting public awareness of randomised clinical trials using the media: the 'Get Randomised' campaign.
Mackenzie IS; Wei L; Rutherford D; Findlay EA; Saywood W; Campbell MK; Macdonald TM.
Br J Clin Pharmacol (Unknown)
Published: 2010
2/6 Transparent
Funding Declared
The effects of sitaxentan on sildenafil pharmacokinetics and pharmacodynamics in healthy subjects.
Stavros F; Kramer WG; Wilkins MR.
Br J Clin Pharmacol (Unknown)
Published: 2010
2/6 Transparent
Funding Declared
Validation and validity of diagnoses in the General Practice Research Database: a systematic review.
Herrett E; Thomas SL; Schoonen WM; Smeeth L; Hall AJ.
Br J Clin Pharmacol (Unknown)
Published: 2010
2/6 Transparent
Funding Declared
Relationship between blood alcohol concentration on admission and outcome in dimethoate organophosphorus self-poisoning.
Eddleston M; Gunnell D; von Meyer L; Eyer P.
Br J Clin Pharmacol (Unknown)
Published: 2009
1/6 Transparent
Tolerability and safety of GS-101 eye drops, an antisense oligonucleotide to insulin receptor substrate-1: a 'first in …
Kain H; Goldblum D; Geudelin B; Thorin E; Beglinger C.
Br J Clin Pharmacol (Unknown)
Published: 2009
2/6 Transparent
Funding Declared
Pharmacokinetics and clinical efficacy of midazolam in children with severe malaria and convulsions.
Muchohi SN; Kokwaro GO; Ogutu BR; Edwards G; Ward SA; Newton CR.
Br J Clin Pharmacol (Unknown)
Published: 2008
2/6 Transparent
Funding Declared
'Real-life' reduction in cholesterol with statins, 1993 to 2002.
Murphy MJ; Wei L; Watson AD; MacDonald TM.
Br J Clin Pharmacol (Unknown)
Published: 2008
2/6 Transparent
Funding Declared
Risk of congenital anomalies in pregnant users of statin drugs.
Ofori B; Rey E; Bérard A.
Br J Clin Pharmacol (Unknown)
Published: 2007
1/6 Transparent
Funding Declared
Effect of renal impairment on the pharmacokinetics of exenatide.
Linnebjerg H; Kothare PA; Park S; Mace K; Reddy S; Mitchell M; Lins R.
Br J Clin Pharmacol (Unknown)
Published: 2007
2/6 Transparent
Funding Declared